Corient Private Wealth LP Sells 26,579 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• Corient Private Wealth reduced its UnitedHealth position by 4.9%, selling 26,579 shares in the second quarter. It still held 520,634 shares worth approximately $216.4 million.
• UnitedHealth reported quarterly EPS of $6.38, beating estimates of $4.94, while revenue reached $112.03 billion. Analysts maintain a “Moderate Buy” consensus with an average price target of $456.56 versus the stock’s $387.69 opening price.
• Turnaround opportunities are balanced by ongoing risks: UnitedHealth is pursuing Optum Health improvements, reduced prior-authorization requirements and substantial AI investment, but elevated medical costs and concerns about the WellMed business continue to pressure sentiment.

Corient Private Wealth LP lowered its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 4.9% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 520,634 shares of the healthcare conglomerate's stock after selling 26,579 shares during the period. Corient Private Wealth LP owned about 0.06% of UnitedHealth Group worth $216,392,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the business. Sarver Vrooman Wealth Advisors purchased a new stake in UnitedHealth Group during the 4th quarter valued at approximately $25,000. Nalls Sherbakoff Group LLC purchased a new position in UnitedHealth Group during the fourth quarter valued at $27,000. Lifetime Wealth Management P.C. bought a new stake in UnitedHealth Group in the 4th quarter valued at $29,000. Wilkerson Advisory Group LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at about $30,000. Finally, Aberdeen Wealth Management LLC purchased a new stake in shares of UnitedHealth Group in the second quarter worth about $31,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

Insider Activity

In related news, CEO Patrick Conway sold 1,169 shares of the business's stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the transaction, the chief executive officer owned 15,328 shares in the company, valued at $5,977,920. The trade was a 7.09% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.19% of the company's stock.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: TPG investment could support Optum Health’s turnaround. UnitedHealth is selling a partial stake in certain Florida WellMed primary-care operations to TPG while retaining an interest. The deal brings local investment and strategic support that management expects could accelerate growth, improve clinic performance and strengthen profitability. UnitedHealth Reshapes Florida WellMed Operations With TPG Deal
• Positive Sentiment: Management continues to point to areas of operational progress. Commentary at the Wells Fargo healthcare conference reportedly indicated stronger Medicare Advantage performance and a steadier Medicaid outlook. Analysts remain constructive in some cases, with the median recent price target above the current trading range. UnitedHealth Wells Fargo Conference Transcript
• Positive Sentiment: Reduced prior-authorization requirements may improve efficiency. UnitedHealthcare plans to remove authorization requirements for additional services beginning October 1, targeting 30% of healthcare services by the end of 2026. The initiative could lower administrative costs and improve relationships with patients and providers, although its financial benefit remains uncertain. UnitedHealth is Removing More Prior Authorizations
• Neutral Sentiment: UnitedHealth is investing heavily in artificial intelligence. Nearly $1.5 billion is being directed toward AI and Optum Insight software, with the goal of increasing efficiency and creating new growth opportunities. The strategy could support longer-term expansion, but it also requires substantial investment before results are visible. UnitedHealth’s AI Strategy
• Negative Sentiment: The WellMed transaction is raising concerns about Optum Health. Investors may view bringing in TPG as evidence that the Florida clinic business needs outside capital or operational assistance. The clinics were among the operations associated with UnitedHealth’s recent profit setbacks, making the deal a reminder that the Optum turnaround remains incomplete. UnitedHealth Sells WellMed to TPG
• Negative Sentiment: Medical-cost and margin concerns continue to weigh on managed-care stocks. Comments from CVS Health about persistently high medical-cost trends hurt sentiment across the sector. UnitedHealth also faces pressure in commercial insurance, while its valuation remains elevated relative to some peers despite slower revenue growth. CVS Still Sees High-Trend Cost Growth

Analysts Set New Price Targets

A number of analysts have issued reports on UNH shares. Mizuho lifted their price objective on UnitedHealth Group from $470.00 to $493.00 and gave the stock an "outperform" rating in a research note on Monday, July 20th. Wells Fargo & Company boosted their price target on shares of UnitedHealth Group from $397.00 to $485.00 and gave the stock an "overweight" rating in a research report on Monday, July 13th. Leerink Partners increased their price objective on shares of UnitedHealth Group from $400.00 to $462.00 and gave the company an "outperform" rating in a research report on Wednesday, June 17th. Wall Street Zen upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Saturday, August 8th. Finally, Piper Sandler set a $477.00 price target on shares of UnitedHealth Group in a report on Thursday, July 16th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and six have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $456.56.

UnitedHealth Group Stock Down 1.4%

NYSE UNH opened at $387.69 on Friday. UnitedHealth Group Incorporated has a 52 week low of $255.96 and a 52 week high of $461.62. The firm has a market capitalization of $347.98 billion, a price-to-earnings ratio of 24.95, a PEG ratio of 1.48 and a beta of 0.61. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.66. The company has a fifty day moving average of $409.50 and a two-hundred day moving average of $367.63.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.94 by $1.44. The firm had revenue of $112.03 billion during the quarter, compared to analyst estimates of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business's revenue was up .4% on a year-over-year basis. During the same quarter last year, the business earned $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 19.82 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th will be issued a $2.32 dividend. This represents a $9.28 annualized dividend and a dividend yield of 2.4%. The ex-dividend date is Monday, September 14th. UnitedHealth Group's dividend payout ratio is presently 59.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a diversified health care and well-being company headquartered in Minnetonka, Minnesota. Its operations are organized primarily through two businesses: UnitedHealthcare, which provides health benefit plans and services, and Optum, which delivers health care services, technology, pharmacy care and data-driven solutions.

UnitedHealthcare serves individuals, employers, government programs and other organizations through products that include employer-sponsored health plans, individual and family coverage, Medicare and Medicaid plans, dental and vision benefits, and related administrative services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.